» Articles » PMID: 28774345

Determination of Optimized Oxygen Partial Pressure to Maximize the Liver Regenerative Potential of the Secretome Obtained from Adipose-derived Stem Cells

Overview
Publisher Biomed Central
Date 2017 Aug 5
PMID 28774345
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A hypoxic-preconditioned secretome from stem cells reportedly promotes the functional and regenerative capacity of the liver more effectively than a control secretome. However, the optimum oxygen partial pressure (pO) in the cell culture system that maximizes the therapeutic potential of the secretome has not yet been determined.

Methods: We first determined the cellular alterations in adipose tissue-derived stem cells (ASCs) cultured under different pO (21%, 10%, 5%, and 1%). Subsequently, partially hepatectomized mice were injected with the secretome of ASCs cultured under different pO, and then sera and liver specimens were obtained for analyses.

Results: Of all AML12 cells cultured under different pO, the AML12 cells cultured under 1% pO showed the highest mRNA expression of proliferation-associated markers (IL-6, HGF, and VEGF). In the cell proliferation assay, the AML12 cells cultured with the secretome of 1% pO showed the highest cell proliferation, followed by the cells cultured with the secretome of 21%, 10%, and 5% pO, in that order. When injected into the partially hepatectomized mice, the 1% pO secretome most significantly increased the number of Ki67-positive cells, reduced serum levels of proinflammatory mediators (IL-6 and TNF-α), and reduced serum levels of liver transaminases. In addition, analysis of the liver specimens indicated that injection with the 1% pO secretome maximized the expression of the intermediate molecules of the PIP3/Akt and IL-6/STAT3 signaling pathways, all of which are known to promote liver regeneration.

Conclusions: The data of this study suggest that the secretome of ASCs cultured under 1% pO has the highest liver reparative and regenerative potential of all the secretomes tested here.

Citing Articles

"Cellularity as a predictive tool for mesenchymal stem cell concentration in bone marrow concentrates: Implications for regenerative medicine".

Labarre K, Grathwol P, Zimmermann G Bone Rep. 2024; 24:101820.

PMID: 39691445 PMC: 11650265. DOI: 10.1016/j.bonr.2024.101820.


Strategies to improve the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicle (MSC-EV): a promising cell-free therapy for liver disease.

Zheng L, Gong H, Zhang J, Guo L, Zhai Z, Xia S Front Bioeng Biotechnol. 2023; 11:1322514.

PMID: 38155924 PMC: 10753838. DOI: 10.3389/fbioe.2023.1322514.


Eupalinolide O Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway.

Zhao Y, Fu L, Chen J, Zhou J, Tian C, Zhou D J Oncol. 2022; 2022:8802453.

PMID: 36185619 PMC: 9519309. DOI: 10.1155/2022/8802453.


Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure.

Ho C, Chen Y, Chien C, Ho S, Chen H, Hu R Korean J Transplant. 2022; 34(2):100-108.

PMID: 35769351 PMC: 9187042. DOI: 10.4285/kjt.2020.34.2.100.


Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms.

Hazrati A, Malekpour K, Soudi S, Hashemi S Front Immunol. 2022; 13:865888.

PMID: 35464407 PMC: 9021384. DOI: 10.3389/fimmu.2022.865888.


References
1.
Wang Y, Deng Y, Zhou G . SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008; 1195:104-12. DOI: 10.1016/j.brainres.2007.11.068. View

2.
Grayson W, Zhao F, Bunnell B, Ma T . Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun. 2007; 358(3):948-53. DOI: 10.1016/j.bbrc.2007.05.054. View

3.
Garcia-Rodriguez J, Barbier-Torres L, Fernandez-Alvarez S, Juan V, Monte M, Halilbasic E . SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology. 2013; 59(5):1972-83. PMC: 3999184. DOI: 10.1002/hep.26971. View

4.
Ahmadi M, Rahbarghazi R, Aslani M, Shahbazfar A, Kazemi M, Keyhanmanesh R . Bone marrow mesenchymal stem cells and their conditioned media could potentially ameliorate ovalbumin-induced asthmatic changes. Biomed Pharmacother. 2016; 85:28-40. DOI: 10.1016/j.biopha.2016.11.127. View

5.
Das R, Jahr H, van Osch G, Farrell E . The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev. 2009; 16(2):159-68. DOI: 10.1089/ten.TEB.2009.0296. View